HZI CIR - Small molecule inhibitors of α-hemolysin for the treatment of S. aureus lung infections
IATI Identifier: US-EIN-04-2103547-Helmhltz CIR
Published on
- date_range Oct 01, 2020 - May 31, 2024
- autorenew Implementation (Status)
- mail Contact
- share Share
TBD
more_horiz
Sectors:
-
Infectious disease control
Participating Organisations
| Name | Type | Role |
|---|---|---|
| HZI CIR | Academic, Training and Research | Implementing |
Transaction
| Transaction Value |
Provider
Receiver |
Type | Date |
|---|---|---|---|
| 338,824 USD (Valued at Jan 25, 2024) | Provider N/A Receiver N/A | Expenditure |
date_range
Jan 25, 2024
|
| 100,000 USD (Valued at Aug 31, 2023) | Provider N/A Receiver N/A | Expenditure |
date_range
Aug 31, 2023
|
Budget
438,824
USD
-
100,000 USD (Valued at Aug 31, 2023)date_range Jul 01, 2022 - Jun 30, 2023
-
338,824 USD (Valued at Jun 08, 2023)date_range Oct 01, 2020 - Oct 31, 2020
access_time
Updated on
Jan 25, 2024 22:33:25